Archive

Author: Marco Propersi

The Pragmatic Combination of YEARS Score and Age-Adjusted D-Dimer

Background: The optimal approach to risk stratifying patients for pulmonary embolism (PE) remains elusive. Multiple decision instruments are available with varying degrees of complexity and acceptance among emergency medicine clinicians (Wells, Geneva, PERC, YEARS, age-adjusted D-dimer). The 2018 ACEP clinical ...

Read More
CardiovascularHematology and OncologyThoracic and Respiratory

The HEP-COVID Trial: Therapeutic Anticoagulation in Non-Critically Ill COVID-19 Patients

Background: Patients with COVID-19 are at increased risk from thromboembolic phenomena. Patient-specific factors such as comorbidities and immobility have been linked to thrombosis. Disease-specific factors such as virus-induced endothelial changes and cytokine storm may also be triggers. Furthermore, patients with elevated ...

Read More
Hematology and OncologyInfectious DiseaseThoracic and Respiratory

REBEL Cast Book Club Episode 2 — The New Jim Crow

Read More

Ketorolac for Acute MSK Pain: 15mg IM vs 60mg IM

The opioid epidemic has ignited a revolution in ED pain management over the last 5+ years. As such, opportunities for research have become more abundant and have driven ED pain management forward. Regional anesthesia, lidocaine infusions, intranasal ketamine, etc., are ...

Read More
Orthopedics

RECOVERY RS: CPAP vs HFNO vs Conventional Oxygen Therapy in COVID-19

Background: Much of the last two years has been both a complete blur and indelibly memorable. This dichotomy is encapsulated by the rapid changes and updates in medical management and hospital algorithms coupled with the memories of frightened faces of ...

Read More
Thoracic and Respiratory

Sponsored